Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Persistent Infection × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 3 Uterine Cervical Dysplasia 2 Papillomavirus Infections 2 Rheumatic Diseases 1 Persistent Infection 1 Neoplasms 1 HIV Infections 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05426148 2022-06-29

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Xiamen Innovax Biotech Co., Ltd

Phase 4 Completed

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡